BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36435661)

  • 21. New and emerging renal entities: a perspective post-WHO 2016 classification.
    Trpkov K; Hes O
    Histopathology; 2019 Jan; 74(1):31-59. PubMed ID: 30565301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma.
    Bedke J; Albiges L; Capitanio U; Giles RH; Hora M; Lam TB; Ljungberg B; Marconi L; Klatte T; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Powles T; Bex A
    Eur Urol; 2022 Feb; 81(2):134-137. PubMed ID: 34920897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell carcinoma: urologists in a new era.
    Uzzo RG
    J Urol; 2005 Nov; 174(5):1723-4. PubMed ID: 16217270
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88.
    Ljungberg B; Bedke J; Capitanio U; Bex A
    Eur Urol; 2022 Oct; 82(4):e111-e112. PubMed ID: 35773149
    [No Abstract]   [Full Text] [Related]  

  • 25. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
    Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2023;83:3-5.
    Tang Y; Hu X; Wu K; Shao Y; Li X
    Eur Urol; 2023 Mar; 83(3):e73. PubMed ID: 36526493
    [No Abstract]   [Full Text] [Related]  

  • 27. [Histopathology of renal cell carcinoma].
    Stöhr CG; Amann K; Hartmann A
    Urologe A; 2013 Jul; 52(7):942-8. PubMed ID: 23801160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006.
    Wei Y; Zhang R; Lin L
    Eur Urol; 2022 Sep; 82(3):e88. PubMed ID: 35750581
    [No Abstract]   [Full Text] [Related]  

  • 29. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.
    Albiges L; Powles T; Staehler M; Bensalah K; Giles RH; Hora M; Kuczyk MA; Lam TB; Ljungberg B; Marconi L; Merseburger AS; Volpe A; Abu-Ghanem Y; Dabestani S; Fernández-Pello S; Hofmann F; Kuusk T; Tahbaz R; Bex A
    Eur Urol; 2019 Aug; 76(2):151-156. PubMed ID: 31151678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?: A 10-Year Single-Center Study.
    Liu N; Gan W; Qu F; Wang Z; Zhuang W; Agizamhan S; Xu L; Yin J; Guo H; Li D
    Am J Pathol; 2018 Apr; 188(4):929-936. PubMed ID: 29571325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiology, novelty in the classification of renal cancer].
    Iurin AG
    Arkh Patol; 2007; 69(1):49-54. PubMed ID: 19385136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
    Fernández-Pello S; Hora M; Kuusk T; Tahbaz R; Dabestani S; Abu-Ghanem Y; Albiges L; Giles RH; Hofmann F; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Powles T; Staehler M; Volpe A; Ljungberg B; Bex A; Bensalah K
    Eur Urol Oncol; 2020 Feb; 3(1):57-72. PubMed ID: 31171501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characterization of different renal cell carcinoma entities].
    Rupp NJ; Moch H
    Urologe A; 2020 Feb; 59(2):135-141. PubMed ID: 31974661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Association of Urology Urolithiasis Guidelines: Where Are We Going?
    Tzelves L; Türk C; Skolarikos A
    Eur Urol Focus; 2021 Jan; 7(1):34-38. PubMed ID: 33011151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Laurence Albiges, Tom Powles, Michael Staehler, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-Cell Renal Cell Carcinoma. Eur Urol 2019;76:151-6: Active Surveillance in Metastatic Renal Cell Cancer: Missing a Chance for Cure?
    de Joode K; van der Veldt AAM
    Eur Urol; 2020 Mar; 77(3):e76-e77. PubMed ID: 31610901
    [No Abstract]   [Full Text] [Related]  

  • 37. Current pathology keys of renal cell carcinoma.
    Algaba F; Akaza H; López-Beltrán A; Martignoni G; Moch H; Montironi R; Reuter V
    Eur Urol; 2011 Oct; 60(4):634-43. PubMed ID: 21741159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging of renal cell carcinoma: current progress and potential advances.
    Delahunt B; Eble JN; Samaratunga H; Thunders M; Yaxley JW; Egevad L
    Pathology; 2021 Jan; 53(1):120-128. PubMed ID: 33121821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The World Health Organization 2022 Classification of renal tumors: key updates for urologists.
    Caliò A; Amparore D; Roussel E; Bertolo R; Erdem S; Marchioni M; Pavan N; Campi R;
    Minerva Urol Nephrol; 2023 Dec; 75(6):766-769. PubMed ID: 38126288
    [No Abstract]   [Full Text] [Related]  

  • 40. Urologic Pathology: Key Parameters from a Urologist's Perspective.
    Borchert A; Rogers CG
    Surg Pathol Clin; 2018 Dec; 11(4):893-901. PubMed ID: 30447847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.